Transcription factors are often targeted for rapid degradation by the ubiquitin-proteasome system. Recent evidence points to a correlation between the potency and instability of transcriptional activators, suggesting a possible direct role for ubiquitindependent proteolysis in transcriptional activation. The ubiquitin proteolytic system often attenuates cellular responses to extracellular cues by rapidly degrading key signalling proteins, from cell surface receptors to nuclear transcription factors. Ubiquitin is covalently attached to substrate proteins by a conserved enzymatic cascade, E1→E2→E3, which assembles a polyubiquitin chain on the substrate, leading to its capture and rapid degradation by the 26S proteasome [1] . The crucial step in the pathway is substrate recognition, carried out by the E3 ubiquitin ligases, which bind to a specific region on the substrate termed a degron. Although the ubiquitin-dependent elimination of numerous transcription factors is well documented, recent studies suggest that the most potent transcriptional activators are highly unstable, perhaps as a very consequence of their efficient interaction with the transcriptional machinery.
In eukaryotes, activation of transcription by RNA polymerase II requires the coordinated assembly of a complex protein machinery, composed of the RNA polymerase II holoenzyme, general transcription factors, chromatin remodeling activities, histone acetylases and gene-specific transcriptional activators [2] . Activators have a modular structure, typically comprising a DNA binding domain that recognizes enhancer sequence elements in the target gene promoter, and one or more activation domains that stimulate RNA polymerase II-dependent gene transcription. Domain swap experiments have revealed that activation domains are functionally autonomous units able to stimulate RNA polymerase II activity when fused to a heterologous DNA binding domain. Activation domains are loosely classified by amino acid composition as acidic, glutamine-rich, proline-rich and isoleucine-rich. In extreme cases, a stretch of six to eight amino acids is sufficient for transcriptional activation. Activation domains make direct protein-protein contacts with RNA polymerase II-associated factors and are believed to stimulate transcription by directing the recruitment of the RNA polymerase II holoenzyme to promoter regions on DNA [3] .
An initial link between activator degradation and transcriptional potency arose from a study of the Myc transcription factor, a powerful regulator of cell proliferation that is normally held in check by ubiquitin-dependent proteolysis. Deletion analysis of Myc showed that its activation domain and degron regions are tightly super-imposed [4] . A subsequent literature survey revealed overlapping activation domains and degrons in numerous other transcription factors [5] . To evaluate the possible functional significance of the destabilizing regions in activators, Salghetti et al. [5] undertook a systematic analysis of various activation domains fused to the same Gal4 DNA binding domain. Independently, while in the course of dissecting transcription factor structure/function relationships, Molinari et al. [6] examined a similar panel of chimeric activators. Both studies unveiled a striking coincidence of activator potency and instability. In particular, the most potent class of transcriptional activators, those rich in acidic residues, are by far the most unstable. In contrast, transcription factors with weak proline-rich or glutamine-rich activation domains are much more stable.
The relationship between activator potency and instability was corroborated by a detailed analysis of synthetic activation domains, consisting of multiple tandem copies of a short acidic fragment derived from the potent activation domain of the HSV viral protein VP16 [5, 6] . As the copy number of the VP16 fragment is increased, so is transcriptional activation and, concomitantly, instability of the chimeric activator. Importantly, single point mutations in the VP16 sequence that abolish transcriptional activation strongly stabilize the chimeric activators. In addition, recruitment of the activator to DNA appears necessary for proficient degradation [6] . The various chimeric activators are targeted by the ubiquitin system, as shown by the accumulation of ubiquitinated forms of the activators in cells treated with proteasome inhibitors. Moreover, the extent of activator ubiquitination is proportional to the number of VP16 repeats [5] . Intriguingly, in pursuing the activation domain-degron connection, Salghetti et al. found that PEST-rich degron domains derived from yeast G1 cyclins, which do not normally participate in transcriptional activation, also function as activation domains when fused to the Gal4 DNA binding domain [5] .
A recent study of the Microphthalmia (Mi) transcription factor by Wu et al. [7] lends further support to the idea that potent activation domains can simultaneously serve as signals for proteolysis. Mi is an essential effector of the c-Kit receptor tyrosine kinase during melanocyte development. Activation of c-Kit by its ligand Steel results in phosphorylation of Mi by two downstream kinases in the signaling pathway, mitogen activated protein (MAP) kinase and Rsk. In turn, phosphorylated Mi recruits a transcriptional coactivator, p300/CBP, to target gene promoters, thereby activating transcription. Once phosphorylated, Mi is also rapidly degraded by the ubiquitin-proteasome system. Mutation of the two relevant serine residues on Mi that are normally phosphorylated abolishes Mi-dependent transcription without affecting the ability of Mi to bind DNA. And correspondingly, the mutant version of Mi is completely refractory to signal-induced degradation.
Taken together, these results argue that transcriptional activation and activator degradation are closely coupled events. It is worth emphasizing that this relationship is the exact converse of that observed in numerous other circumstances, in which inhibition of activator degradation leads to an increase in transcription. A notable example of the latter is the stabilization of p53 and concomitant activation of p53-dependent transcription during the DNA damage response [8] . How might these superficially disparate findings be reconciled? A key difference between the two processes lies in the context of the degradation pathways. On the one hand, the many dedicated pathways that signal turnover of specific activators do so independently of transcriptional status, while on the other hand, the instability of strong activators apparently requires a productive interaction with the RNA polymerase II machinery. That is, in addition to an intact activation domain, proper recruitment of the activator to the promoter is necessary for efficient degradation [6] . In perhaps the simplest model, the RNA polymerase II holoenzyme and/or its cofactors might bridge the activator to the ubiquitination machinery (Figure 1) . In a formal sense, the RNA polymerase II machinery would serve as the substrate recognition component of an E3 ubiquitin ligase.
If this notion is correct, then it should be possible to detect an activator-specific ubiquitin ligase activity associated with the RNA polymerase II holoenzyme or a coactivator complex. A number of components of the ubiquitin-proteasome pathway have been detected in association with the RNA polymerase II machinery, including E3 ubiquitin ligases, ubiquitin hydrolases and subunits of the proteasome (see citations in [5] [6] [7] ). Indeed, an age-old puzzle is the association of mono-ubiquitinated forms of histone H2A with actively transcribed regions of the genome [9] . In a recent intriguing example, the HECT domain E3 enzyme Tom1 was found to be required for efficient transcription of several genes in yeast and physically associates with SAGA, a multisubunit histone acetylase [10] . Perhaps not by chance, the SAGA complex is preferentially recruited by acidic activation domains [11] . Whether it is Tom1 or some other E3 that catalyzes ubiquitination of acidic activators remains to be determined. Delineation of the degradation pathway will also await the identification R342 Current Biology Vol 10 No 9
Figure 1
Ubiquitin-dependent proteolysis of potent transcriptional activators. of the relevant E2 enzyme, and other factors that might regulate the dynamics of ubiquitin conjugation to activators, such as ubiquitin hydrolases. Finally, it will be of considerable interest to determine if components of the general transcriptional machinery are also degraded in concert with intense transcriptional activity.
But why destroy the very factors dedicated in the first place to high level transcription? The obvious possibility is to provide a fail-safe mechanism against unbridled, and hence potentially deleterious, levels of transcription. Similarly, the intrinsic instability of potent activators might allow the transcriptional apparatus to be quickly reprogrammed upon a change in cellular state without the need for degradation pathways tailored to each and every activator. But perhaps the effect has deeper origins. Another unique property of potent acidic activators is their ability to stimulate transcriptional elongation and downstream mRNA processing events [12] . Might this coincidence reflect an unsuspected liaison between efficient elongation and transcription factor degradation?
There is a good deal of evidence indicating that elongation requires phosphorylation of the extensive carboxy-terminal heptad repeat (CTD) domain of the large subunit of RNA polymerase II, a complex event carried out by several resident cyclin-dependent kinases of the transcriptional machinery [13] . It is possible that activator degradation might arise either as a consequence of CTD phosphorylation, perhaps through recruitment of E3 activity to the RNA polymerase II holoenzyme (for example [14] ), or even as a direct result of activator phosphorylation by one or more RNA polymerase II associated kinases (for example [15] ). The ubiquitination machinery often specifically targets phosphorylated substrates and in fact, the yeast G1 cyclin degrons that act as synthetic activation domains when fused to a DNA binding domain are normally targeted for degradation by phosphorylation [5] . It is just conceivable that such degrons might recruit their cognate E3 enzymes to ectopically stimulate the transcriptional machinery.
What specific role could activator degradation play in transcriptional elongation? As an alternative to models in which elongation depends on transactivator-RNA polymerase II holoenzyme dissociation, one might envisage proteolysis of the promoter-bound activator as a way of decoupling the engaged RNA polymerase II complex from the promoter (Figure 1) . In this scenario, on-going transcription would entail continuous reloading of newly synthesized transcription factors, a possibility that has yet to be examined in vivo. A rapid turnover of promoter-bound transcription factors would certainly lend an appealing dynamic edge to the process of RNA polymerase II holoenzyme recruitment. Flights of fancy aside, ubiquitination seems set to claim a place alongside acetylation, methylation and phosphorylation on the list of the biochemical events intimately associated with RNA polymerase II-dependent transcription. So much the worse for the potent activators that are indeed the divine wind of high-level transcription.
